Drug Interactions Flashcards
what are three types of drugs that are most commonly involved in DDIs?
NSAIDs
anticoagulants
cardiovascular drugs
in this type of DI, one drug has a pharmacologic action that increases, decreases, or somehow alters the pharmacologic action of another drug
pharmacodynamic
this type of DI is related to the drug’s effect in the body
one drug modulates the pharmacologic effect of another (addictive, synergistic, or antagonist)
CANNOT be remedied by adjusting the dose of the interacting drugs
pharmacodynamic
in this type of DI, one drug alters the concentration of another drug in the body and usually can be remedied by adjusting the dose of the altered drug
pharmacokinetic
this is a group of enzymes in the liver that are highly involved in drug metabolism
CYP450 enzymes
this type of medication increases the rate of metabolic activity of a specific CYP450 enzyme
inducer
this type of medication decreases the rate of metabolic activity of a specific CYP450 enzyme
inhibitor
this type of medication uses CYP450 enzymes to be metabolized in the liver
substrate
these protein are transporters found in the gut and pump drugs out of the blood stream and into the gut
p-glycoproteins
are these p-glycoprotein inhibitors or substrates?
azole antifungals
ritonavir
verapamil
St. John’s Wort
inhibitor
are these p-glycoprotein inhibitors or substrates?
rivaroxaban
dabigatran- novel oral anticoagulants
substrates
2C9 inhibitors
bactrim
metronidazole
2D6 inhibitors
TCAs
fluoxetine
paroxetine
34A inhibitors
haloperidol
azoles
protease inhibitors
NNRTIs
diltiazem
verapamil
erythromycin
are these inducers or inhibitors?
rifampin
carbamazepine
phenobarbital
phenytoin
ritonavir
efavirenz
St. John’s Wort
Nafcillin
inducers
inducer timeline
2-3 weeks
inhibitor timeline
2-3 days
in what diseases should chronic NSAID use be avoided?
chronic renal insufficiency
heart failure
previous peptic ulcer
what drug should those with heart failure avoid?
diltiazem/ verapamil
what diseases should avoid metformin?
chronic renal insufficiency
heart failure
what diseases should avoid thiazide diuretics?
gout
renal insufficiency (GFR less than 30)
clinical presentations of DI
serious ADR
poor tolerability
decreased efficacy
worsening of disease state
withdrawal symptoms
with prodrugs, will inhibiting CYP450 enzymes increase or decrease active level of drug in the body?
decrease
with prodrugs, will inducing CYP450 enzymes increase or decrease active level of drug in the body?
increase